Frontiers in Chemistry (Apr 2021)

In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes

  • Yentl Van Rymenant,
  • Muhammet Tanc,
  • Roos Van Elzen,
  • An Bracke,
  • Olivier De Wever,
  • Koen Augustyns,
  • Anne-Marie Lambeir,
  • Mark Kockx,
  • Ingrid De Meester,
  • Pieter Van Der Veken

DOI
https://doi.org/10.3389/fchem.2021.640566
Journal volume & issue
Vol. 9

Abstract

Read online

Fibroblast activation protein (FAP) is a proline-selective protease that belongs to the S9 family of serine proteases. It is typically highly expressed in the tumor microenvironment (TME) and especially in cancer-associated fibroblasts, the main cell components of the tumor stroma. The exact role of its enzymatic activity in the TME remains largely unknown. Hence, tools that enable selective, activity-based visualization of FAP within the TME can help to unravel FAP’s function. We describe the synthesis, biochemical characterization, and application of three different activity-based probes (biotin-, Cy3-, and Cy5-labeled) based on the FAP-inhibitor UAMC1110, an in-house developed molecule considered to be the most potent and selective FAP inhibitor available. We demonstrate that the three probes have subnanomolar FAP affinity and pronounced selectivity with respect to the related S9 family members. Furthermore, we report that the fluorescent Cy3- and Cy5-labeled probes are capable of selectively detecting FAP in a cellular context, making these chemical probes highly suitable for further biological studies. Moreover, proof of concept is provided for in situ FAP activity staining in patient-derived cryosections of urothelial tumors.

Keywords